Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 445-448

  Kostrikis, Leondios G ^a   Cao, Yunzhen ^a   Ngai, Helen ^a   Moore, John P ^a   David, D H O ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; ENVELOPE GENE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEROTYPE; VIRUS CHARACTERIZATION; VIRUS NEUTRALIZATION;

AMINO ACIDS; CLUSTER ANALYSIS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMAN; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PHYLOGENY; SEROTYPING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029655566     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.445-458.1996     Document Type: Article

References (64)

1. Abimiku, A. G., T. L. Stern, A. Zwandor, P. D. Markham, C. Calef, S. Kyari, W. C. Saxinger, R. C. Gallo, M. Robert-Guroff, and M. S. Reitz. 1994. Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum. Retroviruses 10:1581-1583
2. Allan, J., J. Strauss, and D. Buck. 1990. Enhancement of SIV infection with soluble receptor molecules. Science 247:1084-1088.
3. Baskar, P. V., S. C. Ray, R. Rao, T. C. Quinn, J. E. K. Hildreth, and R. C. Bollinger. 1994. Presence in India of HIV type 1 similar to North American strains. AIDS Res. Hum Retroviruses 8:1039-1041
4. Bobkov, A., R. Cheingsong-Popov, M. Garaev, A. Rzhaninova, P. Kaleebu, S. Beddows, M. H. Bachmann, J. I. Mullins, J. Louwagie, W. Janssens, G. van der Groen, F. McCutchan, and J. Weber. 1994. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus AIDS Res. Hum. Retroviruses 8:1649-1655.
5. Bruce, C., C. Clegg, A. Featherstone, J. Smith, B. Biryahawaho, R. Downing, and J. Oram. 1994. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res. Hum. Retroviruses 10:1543-1550.
6. Cao, Y., A. E. Friedman-Kien, M. Mirabile, X. L. Li, M. Alam, D. Dieterich, and D. D. Ho. 1990. HIV-1 neutralizing antibodies in urine from seropositive individuals J. Acquired Immune Defic. Syndr. 3:195-199.
7. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virological and immunological characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl. J. Med. 332:201-208.
8. Dietrich, U., M. Grez, H. von Briesen, B. Panhans, M. Geinbendörfer, H. Kühnel, J. Maniar, G. Mahambre, W. B. Becker, M. B. Becker, and H. Rubsamen-Waigmann. 1993. HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS Res. Hum. Retroviruses 8:23-27.
9. Dumitrescu, O., M. L. Kalish, S. C. Kliks, C. I. Bandea, and J. A. Levy. 1994. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype J. Infect. Dis 169:281-288.
10. Earl, P. L., C. C. Broder, D. Long, S. A. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities J. Virol. 68:3015-3026.
11. Engelman, L., S. Fu, J. Frane, and A. Jones. 1992. BMBP (statistical software) version 1. University Press of California, Los Angeles.
12. Felsenstein, J. 1993. PHYLIP (phylogeny inference package) version 3.5. Department of Genetics, University of Washington. Seattle.
13. Gao, F., L. Yue, S. Craig, C. L. Thornton, D. L. Robertson, F. E. McCutchan, J. A. Bradac, P. M. Sharp, B. H. Hahn, and the WHO Network for HIV Isolation and Characterisation. 1994. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. AIDS Res Hum. Retroviruses 10:1359-1368.
14. Gelderblom, H. R., E. H. S. Hausmann, M. Özel, G. Pauli, and M. A. Koch, 1987. Fine structure of immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176
15. Gelderblom, H. R., M. Özel, and G. Pauli. 1989. Morphogenesis and morphology of HIV structure-functions relations. Arch. Virol 106:1-13.
16. Grez, M., U. Dietrich, P. Balfe, H. V. Briesen, J. K. Maniar, G. Mahambre, E. L. Delwart, J. I. Mullins, and H. Rübsamen-Waigmann. 1994. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each virus J. Virol. 68:2161-2168.
17. Hahn, B. H. Personal communication.
18. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N.-C. Sun, and J. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol. 65:489-493.
19. Ho, D. D., M. G. Sarngadharan, M. S. Hirsch, R. T. Schooley, T. R. Rota, R. C. Kennedy, T. C. Chanh, and V. L. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins J. Virol. 61:2024-2028.
20. Homsy, J., M. Meyer, and J. A. Levy. 1990. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J. Virol. 64:1437-1440.
21. Homsy, J., M. Meyer, M. Tateno, S. Clarkson, and J. A. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357-1360.
22. Jain, M. K., T. J. John, and G. T. Keusch. 1994. A review of human immunodeficiency virus infection in India. J. Acquired Immune Defic. Syndr. 7:1185-1194.
23. Janssens, W., L. Heyndrickx, Y. V. de Peer, A. Bouckaert, K. Fransen, J. Motte, G.-M. Gershy-Damet, M. Peeters, P. Piot, and G. van der Groen. 1993. Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire AIDS 8:21-26
24. Janssens, W., L. Heyndrickx, K. Fransen, J. Motte, M. Peeters, J. N. Nkengasong, P. M. Ndumbe, E. Dalaporte, J.-L. Perret, C. Atende, P. Piot. and G. van der Groen. 1994 Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10:877-879
25. Janssens, W., L. Heyndrickx, K. Fransen, M. Temmerman, A. Leonaers, T. Ivens, J. Motte, P. Piot, and G. van der Groen. 1994 Genetic variability of HIV type 1 in Kenya AIDS Res. Hum. Retroviruses 10:1577-1579.
26. Kalish, M. L., C.-C. Luo, B. G. Weniger, K. Limpakarnjanarat, N. Young, C.-Y. Ou, and G. Schochetman. 1994. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res. Hum. Retroviruses 10:1573-1575.
27. Kliks, S. C., T. Shioda, N. L. Haigwood, and J. A. Levy. 1993. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:11518-11522
28. Kohonen, T. 1990. The self-organizing map. Proc IEEE 78:1464-1480.
29. Korber, B. T. M., K. MacInnes, R. F. Smith, and G. Myers. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68:6730-6744.
30. Kostrikis, L. G., E. Bagdades, Y. Cao, L. Zhang, D. Dimitriou, and D. D. Ho. 1995. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus, identification of a new subtype designated subtype I. J. Virol. 69:6122-6130.
31. Kostrikis, L. G., Z.-H. Michalopoulou, and D. D. Ho. Unpublished results.
32. Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. R. van der Hoek, and J. Goudsmit. 1993. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic Proc. Natl. Acad Sci. USA 90:9061-9065.
33. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Brennan, E. Sanders-Buell, G. A. Eddy, G. van der Groen, K. Fransen, G.-M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780
34. McCutchan, F. E., P. A. Hegerich, T. P. Brennan, P. Phanuphak, P. Singharaj, A. Jugsudee, P. W. Berman, A. M. Gray, A. K. Fowler, and D. S. Burke. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum Retroviruses 8:1887-1895.
35. McCutchan, F. E., B. L. P. Ungar, P. Hegerich, C. R. Roberts, A. K. Fowler, S. K. Hira, L. Perine, and D. S. Burke. 1992. Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1 J. Acquired Immune Defic. Syndr 5:441-149.
36. Montefiori, D. C. 1993. In vitro correlates of HIV and SIV humoral immunity and infection enhancement. AIDS Res. Rev. 3:161-180.
37. Montefiori, D. C. Role of complement in HIV and SIV pathogenesis and immunity. In M. M Eible et al. (ed.), Symposium in Immunology. V. Antiviral immunity, in press Springer-Verlag, Heidelberg
38. Moore, J. P. 1995. HIV-1 vaccines: back to primary school. Nature (London) 376:115.
39. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol 70:427-444.
40. Moore, J. P., Y. Cao, L. Qin, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120. and their neutralisation is not predicted by studies with monomeric gp120. J. Virol. 69:101-109
41. Moore, J. P., and D. D. Ho. 1992. Conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
42. Moore, J. P., F. E. McCutchan, S.-W. Poon, J. Mascola, J. Liu, Y. Cao, and D. D. Ho. 1994. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J. Virol. 68:8350-8364.
43. Moore, J. P., H. Yoshiyama, D. D. Ho, J. E. Robinson, and J. Sodroski. 1993. Antigenic variation in gp120s from molecular clones of HIV-1 LAI. AIDS Res. Hum. Retroviruses 9:1185-1193
44. Morgado, M. G., E. C. Sabino, E. G. Shpaer, V. Bongertz, L. Brigido, M. D. C. Guimaraes, E. A. Castilho, B. Galvão-Castro, J. I. Mullins, R. M. Hendry, and A. Mayer. 1994. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F AIDS Res Hum Retroviruses 10:569-576.
45. Murphy, E., B. Kurber, M.-C. Georges-Courbot, B. You, A. Pinter, D. Cook, M.-P. Kieny, A. Georges, C. Mathiot, F. Barre-Sinoussi, and M. Girard. 1993. Diversity of V3 region sequences, of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res. Hum. Retroviruses 9:997-1006.
46. Myers, G. 1994. HIV: between past and future. AIDS Res. Hum. Retroviruses 10:1317-1324.
47. Nkengasong, J. N., W. Janssens, L. Heyndrickx, K. Fransen, P. M. Ndumbe, J. Motte, A. Leonaers, M. Ngolle, J. Ayuk, P. Piot, and G. van der Groen. 1994. Genetic subtypes of HIV-1 in Cameroon. AIDS 8:1405-1412.
48. Ou, C.-Y., Y. Takebe, B. G. Weniger, C.-C. Luo, M. L. Kalish, W. Auwanit, S. Yamazaki, H. D. Gayle, N. L. Young, and G. Schochetman. 1993. Independent introductions of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341:1171-1174.
49. Ozel, M., G. Pauli, and H. R. Gelderblom. 1988 The organization of the envelope projections on the surface of HIV. Arch. Virol 100:255-266.
50. Potts, K. E., M. L. Kalish, C. I. Bandea, G. M. Orloff, M. S. Louis, C. Brown, N. Malanda, M. Kavuka, G. Schochetman, C.-Y. Ou, and W. L. Heyward. 1993. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res. Hum. Retroviruses 9:613-618.
51. Robertson, D. L., P. M. Sharp, F. E. McCutchan, and B. H. Hahn. 1995. Recombination in HIV-1. Nature (London) 374:124-126.
52. Robinson, E., D. C. Montefiori, and W. M. Mitchell. 1987. A human immunodeficiency virus type 1 (HIV-1) infection enhancing factors in seropositive sera. Biochem. Biophys. Res. Commun. 149:693-699.
53. Robinson, W. E., D. C. Montefiori, W. M. Mitchell, A. M. Prince, H. J. Alter, G. R. Dreesman, and J. W. Eichberg. 1989. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees Proc. Natl. Acad Sci. USA 86:4710-4714.
54. Sabino, E. C., E. C. Shpaer, M. G. Morgado, B. T. M. Korber, R. S. Diaz, V. Bongertz, S. Cavalcante, B. Gälvao-Castro, J. I. Mullins, and A. Mayer. 1994. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol. 68:6340-6346.
55. Schutten, M., A. C. Andeweg, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1 Scand. J. Immunol 41:18-22.
56. Smith, R. F., and T. F. Smith. 1992. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng. 5:35-41
57. Stamatatos, L., and C. Cheng-Meyer. 1995. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69:6191-6198.
58. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995 Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
59. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583
60. Trkola, A., A. B. Pomales, H. Yuan, B. Korber, P. J. Maddon, G. P. Allaway, H. Katinger, C. F. Barbas III, D. R. Burton, D. D. Ho, and J. P. Moore. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG J. Virol. 69:6609-6617
61. WHO Network for HIV Isolation and Characterisation. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum. Retroviruses 10:1327-1343
62. Wolf, F., E. Hogervorst, J. Goudsmit, E.-M. Fenyö, H. Rübsamen-Waigmann, H. Holmes, B. Gãlvao-Castro, E. Karita, C. Wasi, S. D. K. Sempala, E. Kuiken, M. Cornelissen, and WHO Network for HIV Isolation and Characterisation. 1994. Syncytium-inducing and non-syncytium capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res. Hum. Retroviruses 10:1387-1400
63. Wolfram, S. 1991. Mathematica (a system for doing mathematics by computer) version 2. The Advanced Book Program, Addison-Wesley Publishing Company, Inc., Redwood City, Calif.
64. Wu, S.-C., J. L. Spouge, S. R. Conley, W.-P. Tsai, M. J. Merges, and P. L. Nara. 1995. Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages. J. Virol. 69:6054-6062.